TP方案诱导化疗序贯同期放化疗治疗局部晚期鼻咽癌效果观察.docVIP

TP方案诱导化疗序贯同期放化疗治疗局部晚期鼻咽癌效果观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
TP方案诱导化疗序贯同期放化疗治疗局部晚期鼻咽癌效果观察

TP方案诱导化疗序贯同期放化疗治疗局部晚期鼻咽癌效果观察   【摘要】 目的:探讨TP方案诱导化疗序贯同期放化疗治疗局部晚期鼻咽癌的效果。方法:以2011年8月-2014年9月收治的130例局部晚期鼻咽癌患者为研究对象,将130例患者随机等分为试验组与对照组,每组65例。试验组行TP方案诱导化疗序贯同期放化疗治疗,对照组行PF方案诱导化疗序贯同期放化疗治疗。比较两组疗效。结果:试验组有效率为67.69%,对照组有效率为69.23%,两组有效率比较差异无统计学意义(P0.05)。试验组中位无进展患者平均生存期为(12.4±3.1)个月,对照组为(9.3±1.6)个月,试验组明显长于对照组,差异有统计学意义(P0.05)。结论:于局部晚期鼻咽癌患者中积极运用TP方案诱导化疗序贯同期放化疗疗法,可延长患者无进展生存时间,值得临床推广应用。   【关键词】 TP方案; PF方案; 局部晚期鼻咽癌; 放化疗; 生存时间   中图分类号 R739.63 文献标识码 B 文章编号 1674-6805(2016)24-0010-02   【Abstract】 Objective:To investigate the efficacy of TP induction chemotherapy combined with concurrent radiochemotherapy for locally advanced nasopharyngeal carcinoma.Method:130 cases of admitted patients with locally advanced nasopharyngeal carcinoma from August 2011 to September 2014 were selected as the research objects.They were randomly grouped as experimental group and control group,each consists of 65 cases.The patients in the experimental group were treated with TP induction chemotherapy combined with concurrent radiochemotherapy,whereas,patients in the control group were treated with PF induction chemotherapy combined with concurrent radiochemotherapy.Then,the curative effect was compared between the two groups.Result:The effective rate of the experimental group was 67.69%,and the effective rate of the control group was 69.23%,the difference between the two groups was not statistically significant(P0.05).The average median progression-free survival time of patients in the experimental group was (12.4±3.1)months,and it was (9.3±1.6)months in the control group,the average median progression-free survival time of the experimental group was longer than that of the control group,the difference was statistically significant(P0.05).Conclusion:The progression-free survival time of the patients can be prolonged by using the TP induction chemotherapy combined with concurrent radiochemotherapy,it is worthy of clinical application.   【Key words】 TP scheme; PF scheme; Locally advanced nasopharyngeal carci

文档评论(0)

fangsheke66 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档